DGAP-News

H&R AG confirms good preliminary Q1 figures

DGAP-News: H&R AG / Key word(s): Quarter Results/Interim Report
H&R AG confirms good preliminary Q1 figures

15.05.2015 / 09:28

---------------------------------------------------------------------

Press release

H&R AG confirms good preliminary Q1 figures

- EBITDA doubled

- Significant growth reported in refining segment

- All three segments report positive ongoing results

Salzbergen (Germany), May 15 2015. H&R AG has confirmed its preliminary
sales and profit figures for the first part of 2015: In the first quarter
the company achieved, with sales of EUR 263.0 million (6.9% lower than in
the
same quarter of the year before; Q1-2014: EUR 282.6 million), a doubling of
earnings before interest, taxes, depreciation and amortization (EBITDA) to
EUR 15.5 million in total (equivalent period of the previous year: EUR 7.7
million). The quarter just finished also made positive contributions to
results at all levels.

Overview of the main figures:

in EUR million                                  Q1-2015  Q1-2014*    Change
Sales revenues                                    263.0     282.6     -19.6
Operating income/loss (EBITDA)                     15.5       7.7       7.8
EBIT                                                8.1       2.1       6.0
Earnings/loss before taxes                          5.0      -1.6       6.6
Consolidated earnings after                         4.8      -1.1       5.9
minority interests
Consolidated earnings per share (EUR)*             0.13     -0.04      0.17
Operating cash flow                                -3.0     -29.6      26.6
Free cash flow                                     -8.8     -32.5      23.7
                                               31.3.2015 31.12.20    Change
                                                               14
Total assets                                      704.5     706.6      -2.1
Shareholders' equity                              267.0     248.9      18.1
Equity ratio (%)                                   37.9      35.2       2.7

* A comparison of earnings per share before / after the increase in
capital through a contribution-in-kind is only possible to a limited
extent, given the different numbers of shares involved.

The segment represented by ChemPharm Refining made an important
contribution to these improved results, despite a raw-material cost related
23.3% drop in sales of EUR 168.2 million (Q1 2014: EUR 219.3 million) with